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Introduction
The UK Department of Health has recently published a national service framework for coronary artery disease, which aims to coordinate efforts to improve medical care of patients by the implementation of minimal standards of care and audit.
1 Many risk models have been derived in an attempt to reliably compare care at different centres. It is self evident that if a doctor or hospital is responsible for a high proportion of sick patients then simply assessing crude mortality will result in an unfavourable comparison of care. Most of the risk-adjusted models that have been derived suffer from overcomplexity, exclude substantial proportions of patients with higher risk profiles, use administrative data without clinical details, or are applicable only to selected subgroups. 23 We have developed a model based on three objective admission clinical characteristics-age, heart rate, and systolic blood pressure. We have validated our model with subgroups of our patients with acute myocardial infarction, and it seems to accurately reflect patient outcome. [4] [5] [6] Scoring systems, such as the Parsonnet score, 7 have been used to assess individual surgeons' performance by comparing actual and expected death rates. Lovegrove et al have described the variable lifeadjusted display, 8 a graphical technique based on the cumulative sum (cusum) method 91 0 that incorporates information of estimated risks for each individual case. Cusum charts record successive cases horizontally, with plots ascending by single units for each outcome event (such as death) reached. The variable life-adjusted display incorporates outcome information, simultaneously accounting for prior estimated risk in each case and plotting the difference in cumulative expected and observed mortality. Sherlaw-Johnson et al recently described a method for estimating variability for such displays in order to assess the probability that observed deviations occurred as a result of chance rather than because of a difference in quality of care.
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In this study we extend the use of variable life-adjusted displays in combination with a simple, accurate, and validated risk model for assessing care of patients with acute myocardial infarction and suggest indications for more detailed review of patient care. management of acute coronary events (EMMACE) study were identified in the 20 adjacent hospitals that comprised all units in the former Yorkshire region that admitted patients with acute myocardial infarction. We identified potential recruits from coronary care registers, clinical coding, and biochemistry records of requests for cardiac enzyme assays. We evaluated the patients' medical records and confirmed 2153 consecutive cases of acute myocardial infarction according to either the World Health Organization's criteria or to the clinical diagnosis reached by the attending physician. We included these 2153 patients, of whom 1643 were discharged from hospital alive after a first myocardial event, in our study. For data abstraction, we applied a hierarchical system of preferred data sources to maintain consistency among our research assistants: for example, we used the first recorded blood pressure and heart rate obtained from either the accident and emergency department or from medical or nursing notes.
Subjects and methods

Patient population
We completed a 250 item record of demographic, clinical, and treatment variables for each patient according to a standardised operations manual and entered the data on a computer database. We included all consecutive patients with acute myocardial infarction regardless of age or place of care within a hospital. We considered only patients' first presentation with acute myocardial infarction (during the recruitment window), and patients transferred to a tertiary centre were counted only once for their index admission. We recorded patients' clinical characteristics on admission from the following sources in order of preference: (a) emergency department medical notes, (b) the admitting medical team's first clerking, or (c) nursing notes.
Calculation of expected mortality
We developed and externally validated a risk model with a demonstrable clinical utility in stratifying patients after myocardial infarction. 45 The model calculates an individual's probability of death at 30 days (P 30 ) on the basis of three robust admission characteristics (age, heart rate, and systolic blood pressure). The calculation is P 30 = 1/(1 + exp( − L 30 )), where L 30 = − 5.624 + (0.085×age) + (0.014×heart rate) − (0.022×systolic blood pressure). In our patient cohort its accuracy was demonstrated by the area under the receiver-operating characteristics (ROC) curve of 0.78. For the patients studied, the mean expected 30 day mortality was 23.5% and the observed mortality was 24.4%, giving a standardised mortality ratio of 1.04.
Variable life-adjusted display
Using the variable life-adjusted display, we can illustrate the cumulative mortality for a hospital or an individual doctor and the variation either side of that predicted. By calculating a patient's expected probability of death after myocardial infarction, we can also estimate the probability of survival. The line plotted in this graphical display varies about zero, ascending, for a patient who survives, by an amount equivalent to the estimated probability of death. For those patients who die by 30 days, the plot descends by an amount equal to the estimated probability of survival. It can be shown that there is a proportionally greater shift in the plot for patients with unexpected outcomes.
We examined two hospitals for variations in risk-adjusted 30 day survival over the three month period of study-hospital A, the smallest of the district hospitals studied, and hospital B, the supraregional tertiary referral centre for the area.
Results
The variable life-adjusted displays (figs 1 and 2) show the number of cases on the x axis and the cumulative difference between the predicted and observed deaths on the y axis. Figure 1 shows the results for hospital A, the centre with the highest standardised mortality ratio. This small hospital had a series of only 30 patients with acute myocardial infarction. The observed and expected mortalities were 44.2% and 27.5% respectively (standardised mortality ratio 1.61). The risk model would predict eight deaths, whereas the actual 
that predicted for the first 15 patients followed by a run of unexpectedly high mortality. Figure 2 shows the for hospital B, which admitted 188 patients with acute myocardial infarction during the study period. The plot terminates with 3.5 extra "lives" above expected (observed number of deaths 42, expected 45.5; standardised mortality ratio 0.92). Between case numbers 35 and 135 the plot ascends from a cumulative (expected minus observed) net lives gained of − 4to7.
Discussion
Using just patients' age, blood pressure, and heart rate to adjust for case mix, we derived a continuous plot to compare observed and expected outcome for patients with acute myocardial infarction.
The main purpose of audit is to provide high quality data analyses with which to monitor the required standards and to allow clinicians to evaluate the performance of their units. Block audit, however, is retrospective and does not allow immediate identification, and thus rectification, of potential problems. With application of a simple risk-adjusted model to populations of patients with acute myocardial infarction, we have produced variable life-adjusted displays. Such plots have become increasingly integrated into surgical care, allowing immediate monitoring of performance for individual surgeons or units over time, but they are not yet used in routine audit of medical patients.
Recently, Sherlaw-Johnson et al showed that prediction intervals can be derived for plots of standardised mortality ratio, with the preoperative case mix taken into account. 11 We did not calculate prediction intervals for our populations because we consider that the usefulness of the graphical displays is enhanced by being qualitative rather than quantitative. We do not consider that achievement ofaPv alue less than 0.05 is helpful in the context of continuous, real time monitoring, nor should it provide evidence that is not in keeping with other qualitative indicators. For example, if hospital B (fig 2) had a major shortage of beds in its coronary care unit beds that coincided with the period of increased deaths, actions might be taken even without a significant P value. Although an apparent run of poor results may not represent a real change, a failure to act on the qualitative trend observed until a significant P value had been achieved could result in the needless loss of life.
Our display method of monitoring performance or outcome over time can be used as an early warning system to allow more detailed audit to be performed. 12 For example, the sharp descent of the plot in the second half of figure 1 highlights the possibility of poor performance. Conversely, in figure 2 the graph ascends from a cumulative net lives saved of − 4t o7i nt h e space of 100 consecutive cases, suggesting that any possible problem in the hospital was identified and corrected. Such periods of poor or above average performance are liable to be missed with block audit, especially when the overall figures are not significantly different from those forecast. As stated by de Mol when commenting on the original description of the variable life-adjusted display, 13 differences in care measured by patient outcome are common. A judgment of whether this performance is above or below average could be based on predefined limits in order to adequately identify important outliers as well as permitting more cost effective and logical use of audit time. However, we would further suggest that rigorous application of a P value (which is itself subject to errors in the context of multiple observations) may mean that early qualitative trends towards harm remain unheeded. Solely relying on quantification of variability in performance rather than a qualitative assessment is therefore laden with shortcomings.
14 A hypothetical example of this limitation is that 16 of 160 patients would have to die after routine cardiac surgery (10% mortality) before a statistically significant doubling of deaths could be detected with 90% chance. 15 16 Common sense suggests that such a trend should be identified and corrected long before the problem was so far progressed, especially if other strong qualitative indicators were present.
Any risk model can become less accurate over time because of progressive improvements in care. The Parsonnet scoring system, derived in 1989, has consistently been shown to predict risk strata that correlate with the observed mortality in adult acquired heart disease. However, it equally consistently overestimates the risk of contemporary coronary surgery by up to 100%.
71 71 8 In order to avoid this problem if our model were to be in general use, we would recommend that patients' heart rate and blood pressure on admission should be added to the core dataset of the national service framework for coronary artery disease. If hospitals were then to provide the data required for the risk model to a centralised database the model could be continually updated and made available on the internet. This would reduce the likelihood of overestimating risk in patients with acute myocardial infarction.
What is already known on this topic
The national service framework for coronary artery disease requires minimal standards of care and audit of patients with acute myocardial infarction but does not integrate clinical status into the audit tool Predictive models using only a few factors to adjust for case mix are easy to use and may be as accurate as more complicated methods Early identification of variations in patient outcome is not revealed by block audit, and, instead, a continuous monitoring process is required
What this study adds
Using just patients' age, blood pressure, and heart rate to adjust for case mix, a continuous plot can be derived to compare observed and expected outcome for patients with acute myocardial infarction This method of monitoring outcome over time can be used as an early warning system to allow more detailed audit to be performed Information in practice 326 BMJ VOLUME 323 11 AUGUST 2001 bmj.com
As stated in the national service framework documentation, good quality data can provide a powerful engine for change and improvement. The method we describe constitutes an improvement over simple clinical intuition and has a potentially important role in indicating the need for more detailed audit. In the interests of patient safety, we suggest that there is a need for continuous, qualitative observations of deviations from expected outcomes.
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Life hangs on chance and the generosity of others Laura came to us from the paediatric cystic fibrosis centre when she was 16 years old. She had severe lung disease and been placed on the transplant list in January 1997. She had just completed her GCSEs and had got top marks. She had just started her A levels and wanted to study theatre and drama at university. Her disease progressed; we put her on to overnight ventilation and permanent intravenous antibiotics. Our patients listed for transplantation continued to die on the waiting list because of the shortage of donors. Laura's activities became more limited at school, and she needed help with mobility and portable oxygen. Characteristically, despite her limitations and against advice, she went on theatre trips to London and Dublin. Last summer, she completed her A levels and came into hospital exhausted from her efforts. She picked up a cold in hospital and deteriorated. Her chest radiograph showed confluent shadowing associated with terminal disease.
Claire, a close friend with severe disease, came back from holiday with a severe chest infection. Laura and Claire were too breathless to visit each other, although they were only a few rooms apart. Claire failed to respond and became breathless despite high flow oxygen. She asked us to allow her to die comfortably. We withdrew the antibiotics, and she died comfortably surrounded by her family.
Laura had now been in hospital for seven weeks and was bedbound. I told her mother that she would probably die. We informed the transplant team that the situation was desperate. Laura had now been on the transplant list for three years. At the ward round, we decided that medical treatment had failed and agreed to discuss with Laura as to whether she would like us to stop treatment as she was suffering so much. I went to see her on my own at the end of the ward round to talk to her about dying, but, just as I started, the sister came in to tell me the senior transplant surgeon was on the phone; I had talked to him that morning about potential donors and he wondered whether Laura was now too sick to transplant. Now he told me that they had found a suitable donor.
I went back to Laura and now spoke to her about living rather than the dying as I had intended a few moments before. That night Laura received her transplant. After a stormy postoperative period, she was extubated on the day the A level results came out; her university place was assured with two As and a B. Nearly a year later she continues to prosper, talking continuously, taking a gap year before university, and sending emails under the name of demolition babe (I thought at first it was a virus).
We don't have enough organ donors. Other countries do better than us. The current government needs to do more, but currently two out of three transplant units (Sheffield, Birmingham, and Manchester) are proposed to close. Although all three sites were inspected over a year ago, the government has still not released the decision.
How can organ donation be improved? It might help if it was known that the current minister of health was on the donor registry. Is the prime minister? How many members of the cabinet are on the donor registry? The number of people carrying donor cards might increase if there was top down government support. 
